Table 2 Characteristics of the 14 follow–up DF patients and healthy, non-dengue fever control
From: The clinical significance of myeloid-derived suppressor cells in dengue fever patients
Variables | 14 follow-up DF patients (fever duration) | Healthy (n = 30) | NDF (n = 20) | |||
|---|---|---|---|---|---|---|
Day 1–2 | Day 3–4 | Day 5–6 | Day 7–8 | |||
men/women | 8/14 | / | / | / | 18/12 | 12/8 |
Age (yr) [range (avg)] | 29 (18–50) | / | / | / | 26 (19–46) | 28 (21–52) |
Plasma Dengue RNA median IU/m (range) | 6.08 × 107 (2.1 × 103–1.38 × 108) | 3.41 × 107 (231–2.39 × 108) | 2.86 × 103 (118–1.63 × 107) | 349 (40.5–4.86 × 104) | / | / |
ALT median U/L(range) | 29 (18–89) | 34 (18–89) | 104 (19–291) | 103 (20–582) | / | / |
Temperature median °C (range) | 39.1 (37.8–40) | 39 (37–40) | 37 (36.3–37.6) | 36.5 (36.2–37) | / | / |
WBC median /L (range) | 4.08 × 109 (1.4 × 109–7.9 × 109) | 3.5 × 109 (1.4 × 109–7.5 × 109) | 3.93 × 109 (1.81 × 109–5.4 × 109) | 5.04 × 109 (2.15 × 109–5.8 × 109) | / | / |
PLT median /L (range) | 137 × 109 (71 × 109–217 × 109) | 123 × 109 (67 × 109–217 × 109) | 130 × 109 (66 × 109–297 × 109) | 226 × 109 (45 × 109–377 × 109) | / | / |
Prothrombin time (PT) median S (range) | 15.9 (14–17) | 15.4 (12–18) | 13 (12–14) | 15.6 (12–17) | / | / |
INR median (range) | 1.3 (1.18–1.49) | 1.27 (0.92–1.55) | 1.0 (0.9–1.02) | 1.25 (0.88–1.55) | / | / |